The lead candidate C5 elicits cancer cell proliferation inhibition specifically in monocarboxylate transporter 1–expressing murine breast cancer cells 4T1 and 67NR, consistent with its ability to accumulate intracellular lactate. This evidence concerns the gene SLC16A1 and breast carcinoma.